132 related articles for article (PubMed ID: 12480282)
1. Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
Udata C; Patel J; Pal D; Hejchman E; Cushman M; Mitra AK
Int J Pharm; 2003 Jan; 250(1):157-68. PubMed ID: 12480282
[TBL] [Abstract][Full Text] [Related]
2. Transport of cosalane-a highly lipophilic novel anti-HIV agent-across caco-2 cell monolayers.
Pal D; Udata C; Mitra AK
J Pharm Sci; 2000 Jun; 89(6):826-33. PubMed ID: 10824142
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption and biodistribution of cosalane and its amino acid conjugates: novel anti-HIV agents.
Kuchimanchi KR; Gandhi MD; Sheta RR; Johnston TP; Santhosh KC; Cushman M; Mitra AK
Int J Pharm; 2002 Jan; 231(2):197-211. PubMed ID: 11755272
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats.
Kuchimanchi KR; Udata C; Johnston TP; Mitra AK
Drug Metab Dispos; 2000 Apr; 28(4):403-8. PubMed ID: 10725308
[TBL] [Abstract][Full Text] [Related]
5. Intestinal safety of water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells.
Tötterman AM; Schipper NG; Thompson DO; Mannermaa JP
J Pharm Pharmacol; 1997 Jan; 49(1):43-8. PubMed ID: 9120769
[TBL] [Abstract][Full Text] [Related]
6. Cosalane and its analogues: a unique class of anti-HIV agents.
Zhan P; Li Z; Liu X
Mini Rev Med Chem; 2010 Sep; 10(10):966-76. PubMed ID: 20540707
[TBL] [Abstract][Full Text] [Related]
7. Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers.
Udata C; Mitra AK; Badr MZ
Drug Metab Dispos; 1999 Aug; 27(8):947-50. PubMed ID: 10421624
[TBL] [Abstract][Full Text] [Related]
8. Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.
Kuchimanchi KR; Ahmed MS; Johnston TP; Mitra AK
J Pharm Sci; 2001 May; 90(5):659-66. PubMed ID: 11288110
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
Cushman M; Insaf S; Ruell JA; Schaeffer CA; Rice WG
Bioorg Med Chem Lett; 1998 Apr; 8(7):833-6. PubMed ID: 9871550
[TBL] [Abstract][Full Text] [Related]
10. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
Takahashi Y; Kondo H; Yasuda T; Watanabe T; Kobayashi S; Yokohama S
Int J Pharm; 2002 Oct; 246(1-2):85-94. PubMed ID: 12270611
[TBL] [Abstract][Full Text] [Related]
11. Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements.
Keyes RF; Golebiewski WM; Cushman M
J Med Chem; 1996 Jan; 39(2):508-14. PubMed ID: 8558520
[TBL] [Abstract][Full Text] [Related]
12. Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
Santhosh KC; Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Mar; 44(5):703-14. PubMed ID: 11262081
[TBL] [Abstract][Full Text] [Related]
13. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Cushman M; Insaf S; Paul G; Ruell JA; De Clercq E; Schols D; Pannecouque C; Witvrouw M; Schaeffer CA; Turpin JA; Williamson K; Rice WG
J Med Chem; 1999 May; 42(10):1767-77. PubMed ID: 10346929
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
[TBL] [Abstract][Full Text] [Related]
15. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid.
Venkatesh S; Li J; Xu Y; Vishnuvajjala R; Anderson BD
Pharm Res; 1996 Oct; 13(10):1453-9. PubMed ID: 8899834
[TBL] [Abstract][Full Text] [Related]
17. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.
Bak A; Gudmundsson OS; Friis GJ; Siahaan TJ; Borchardt RT
Pharm Res; 1999 Jan; 16(1):24-9. PubMed ID: 9950274
[TBL] [Abstract][Full Text] [Related]
18. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
19. Effect of β-cyclodextrin derivatives on the diosgenin absorption in Caco-2 cell monolayer and rats.
Okawara M; Tokudome Y; Todo H; Sugibayashi K; Hashimoto F
Biol Pharm Bull; 2014; 37(1):54-9. PubMed ID: 24389481
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Cushman M; Golebiewski WM; McMahon JB; Buckheit RW; Clanton DJ; Weislow O; Haugwitz RD; Bader JP; Graham L; Rice WG
J Med Chem; 1994 Sep; 37(19):3040-50. PubMed ID: 7932526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
